Publications by authors named "Joy Atienza"

Claim this Profile
O
Optimization of mTOR Inhibitors Using Property-Based Drug Design and Free-Wilson Analysis for Improved In Vivo Efficacy.
Sean T Murphy, Joy Atienza, Jason W Brown, Zacharia S Cheruvallath, Matthew J Cukierski

ACS Med Chem Lett· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [C]PHNO PET.
Eugenii A Rabiner, Tolga Uz, Ayla Mansur, Terry Brown, Grace Chen, Joy Atienza

Neuropsychopharmacology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational discovery of a highly novel and selective mTOR inhibitor.
Stanley Jin, Satoshi Mikami, Nick Scorah, Young Chen, Petro Halkowycz, Joy Atienza

Bioorg Med Chem Lett· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors.
Mark Sabat, Haixia Wang, Nick Scorah, J David Lawson, Joy Atienza

Bioorg Med Chem Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors.
Haixia Wang, J David Lawson, Nick Scorah, Ruhi Kamran, Mark S Hixon, Joy Atienza

Bioorg Med Chem Lett· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis